Ana Paula de Faria Selected Research

Ana Paula de Faria Research Topics

15	Hypertension (High Blood Pressure) 11/2019 - 10/2014
3	Cardiomegaly (Heart Hypertrophy) 04/2017 - 04/2016
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2017 - 04/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2017 - 10/2014
2	Obesity 04/2017 - 10/2014
1	Hemorrhage 01/2020
1	Inflammation (Inflammations) 11/2019
1	Diabetes Mellitus 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2014
1	Coronary Disease (Coronary Heart Disease) 10/2014

3	Matrix Metalloproteinases (MMPs)IBA 07/2017 - 10/2016
3	Tissue Inhibitor of Metalloproteinase-2IBA 07/2017 - 10/2016
3	AldosteroneIBA 01/2017 - 10/2014
3	Antihypertensive Agents (Antihypertensives)IBA 01/2016 - 10/2014
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2017 - 10/2016
2	AdipokinesIBA 10/2014 - 10/2014
1	TicagrelorIBA 01/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020
1	CytokinesIBA 11/2019
1	Interleukin-6 InhibitorsIBA 11/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	EnzymesIBA 07/2017
1	Leptin ReceptorsIBA 04/2017
1	LeptinIBA 04/2017
1	Mineralocorticoid Receptor AntagonistsIBA 01/2017
1	AngiotensinsIBA 01/2017
1	ReninIBA 01/2017
1	Sildenafil Citrate (Viagra)FDA Link 11/2016
1	P-SelectinIBA 04/2016
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2016
1	SelectinsIBA 04/2016
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	E-SelectinIBA 04/2016
1	Triamterene (Dyrenium)FDA LinkGeneric 01/2016
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2016
1	Dipyridamole (Persantine)FDA LinkGeneric 02/2015

1	Therapeutics 11/2019
1	Complementary Therapies (Alternative Medicine) 11/2019
1	Denervation 02/2016